Adjusted earnings reached $2.80 a share, notably exceeding the $2.51 consensus estimate from FactSet analysts. The company successfully placed 468 surgical systems during the quarter, a sharp increase from the 395 units reported during the same period last year. Management now anticipates worldwide da Vinci procedure growth to land between 14% and 15% for the full year.
In section Market Quotes
Intuitive Surgical Posts Strong Growth Amid Rising Robot Competition
With net income climbing to $818.1 million, Intuitive Surgical outperformed Wall Street expectations in the second quarter. Driven by a surge in procedure volume and an expanded installed base of its da Vinci systems, the medical robotics manufacturer saw revenue rise 19% to $2.89 billion, comfortably beating analyst projections of $2.82 billion.
Despite the fiscal momentum, the market for robotic-assisted surgery is tightening. Rival manufacturers are aggressively expanding their footprints; Stryker officially launched its Mako robotic power system for total knee replacements in the U.S. this week. Simultaneously, Medtronic is currently pursuing regulatory clearances to broaden the clinical applications of its Hugo system to include gynecologic and general surgery.
Comments (0)
No comments yet. Be the first!